Flatiron Health Secures $175 Million in Series C Funding Led by Roche to Advance Oncology Cloud Platform

In 2015, VCBeat published an article titled “Flatiron Health: One of the 30 Most Notable Healthcare Startups to Watch in 2015”, the article explains how two young men, Nat Turner and Zach Weinberg, used big data analytics to tackle the global challenge of cancer.

In May 2014, Flatiron Health secured $130 million in Series B financing, led by Google Ventures. Less than two years later, the company recently announced the completion of a $175 million Series C funding round. This round was led by Roche, with participation from Allen & Company, Baillie Gifford, and Casdin Capital.

Turner, Co-founder and CEO of Flatiron Health, stated: “Since founding Flatiron Health in 2012, we have been dedicated to developing the most advanced oncology cloud platform to enhance the quality and value of patient care. Today, our company has made significant progress. By securing funding for our oncology cloud platform and partnering with the rapidly expanding Flatiron Provider Network, we are now positioned to strengthen our core service capabilities. Our company was founded with the mission of leveraging technology to fight cancer, although achieving this goal is a long-term endeavor that cannot be accomplished by a single company alone.”

According to VCBeat, Flatiron Health will invest the new funding into its oncology cloud platform. This platform is being further developed in two areas: the first is OncoAnalytics, the premier advanced analytics tool for oncology data; the second is OncoEMR, the industry-leading electronic health record (EHR) solution in oncology.

OncoAnalytics

OncoEMR

In the coming years, those investments will include:

• Next-Gen OncoEMR




• Update the Company’s Portfolio of Value-Based Care Programs




• New Features and Enhancements to OncoAnalytics, OncoBilling Practice Management Solutions, and the SeeYourChart Patient Portal